Previous 10 | Next 10 |
Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating safer and more efficacious cell and gene therapies, today announced that it has initiated its c...
Gainers: Genfit (GNFT) +15%, Evogene (EVGN) +13%, Marinus Pharmaceuticals (MRNS) +11%, Endo International (ENDP) +8%, Happiness Biotech Group (HAPP) +7%.Losers: Rite Aid (RAD) -10%, Cellect Biotechnology (APOP) -8%, Kaleido...
Gainers: Owens & Minor OMI +53%, Kaleido Biosciences (KLDO) +39%, LogicBio Therapeutics (LOGC) +30%, Cellect Biotechnology (APOP) +25%, Neuronetics (STIM) +6%.Losers: MediciNova MNOV -20%, Rite Aid RAD -17%, ADiTx Therapeut...
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations Tel Aviv, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technol...
TEL AVIV, Israel , Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the second quarter ended June 30, 2020 . The Com...
European Patent Office has granted Cellect Biotechnology ( APOP +3.6% ) a Patent Application no. 14851547.1 for Apograft, covering the activation of the stem and progenitor cells. More news on: Cellect Biotechnology Ltd., Healthcare stocks news, Read more ...
TEL AVIV, Israel , Aug. 6, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as Eur...
TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the first quarter ended March 31, 2020 and provided a...
TEL AVIV, Israel , May 18, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has signed a development agreement with an international consortium to examine the ...
Genfit SA (NASDAQ: GNFT ) -67% after elafibranor flunks NASH study. More news on: Genfit SA, California Resources Corporation, Rand Capital, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...